期刊文献+

中耳胆脂瘤上皮中Livin、p73的表达与其发生关系研究 被引量:1

Expression of Livin and p73 in human middle ear cholesteatoma
下载PDF
导出
摘要 目的观察凋亡抑制蛋白家族成员Livin及p53基因家族成员p73在中耳胆脂瘤上皮的表达情况,探讨它们在胆脂瘤发病机制中的作用。方法采用免疫组织化学技术SP法(streptavidin-perosidase,链霉菌抗生物素蛋白-过氧化物酶连结法)检测30例胆脂瘤标本及16例外耳道正常皮肤组织中的Livin及p73的表达情况,并结合胆脂瘤对听小骨骨质破坏程度,采用SPSS10.0软件包进行统计学分析。结果 Livin表达于细胞核及部分细胞质,而p73表达于胞浆,上述两指标在中耳胆脂瘤中的阳性表达率分别为76.7%、40%,Livin在胆脂瘤上皮中的表达高于外耳道正常皮肤(P<0.05),而p73在胆脂瘤及外耳道皮肤中的表达差异无显著性(P>0.05),听小骨骨质破坏程度与上述指标的表达差异无统计学意义(P>0.05)。结论 Livin在中耳胆脂瘤的异常表达可能在胆脂瘤的发生、发展过程中起相应作用,可能参与胆脂瘤上皮的凋亡调控过程,而p73在中耳胆脂瘤的发生和发展中的作用尚难确定。 Obejective To study expression of Livin and p73 in human middle ear cholesteatoma and their roles in the development of cholesteatoma. Methods Thirty cholesteatoma specimens and sixteen normal external ear canal skin specimens were stained using immunohistochemical SP method to detect expression of Livin and p73. The correlation between Livin and p73 expression with the degree of ossicular destruction was analyzed. Results Expression of Livin was seen in the nuclei as well as the cytoplasm. Staining of p73 was located in cell membrane. Their expression rates were 76.7% and 40%, respectively. Expression of Livin in the cholesteatoma epithelialium was higher than in normal epithelialium (P 0.05), while expression of p73 was not significantly different (P 0.05). Their expression was not correlated to ossicular bone destruction (P 0.05). Conclusion Increased expression of Livin in the cholesteatoma epithelium suggests their important roles in the formation and development of cholesteatoma, maybe through regulation of apoptosis in the cholesteatoma epithelium. p73 does not appear to play a role in middle ear cholesteatoma.
作者 彭利 刘立中
出处 《中华耳科学杂志》 CSCD 2010年第3期315-318,共4页 Chinese Journal of Otology
关键词 胆脂瘤 中耳 LIVIN P73 凋亡 免疫组织化学 Cholesteatoma Middle ear Livin p73 Apoptosis Immunohistochemistry
  • 相关文献

参考文献15

  • 1Saleh HA,Mills RP.Classification and staging of cholesteatoma.Clin Otolaryngol Allied Sci,1999,24(4):355-359.
  • 2Olszewska E,Chedynicki S,Chyesewski L[Evaluation of epithelial proliferation and apoptosis in chelesteatoma of adults].Otolaryngol Pol,2003,57(1):85-89.
  • 3Lin JH,Deng G,Huang Q,et al.KIAP,a novd member of the inhibitor of apoptesis protein family.Biochem Biophys Res Commun,2000,279(3):820-831.
  • 4Vucic D,Stennicke HR,Pisabarro MT,et al.ML-IAP,a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.Curr Biol,2000,10(21):1359-1366.
  • 5Kasof GM,Comes BC.Livin,a novel inhibitor of apoptosis protein family member.Biol Chem,2001,276(5):3238-3246.
  • 6Ashhab Y,Allan A,Polliack A,et al.Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern.FEBS Lett,2001,495(1-2):56-60.
  • 7Gazzaniga P,Gradilone A,Giuliani L,et al.Expression and prognostic significance of LIVIN,SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.Ann Onco,2003,14(1):85-90.
  • 8Yagihashi A,Asanuma K,Tsuji N,et al.Detection of anti-livin antibody in gastrointestinal cancer patients.Clin Chem,2003,49(7):1206-1208.
  • 9Tanabe H,Yagihashi A,Tsuji N,et al.Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.Lung Cancer,2004,46(3):299-304.
  • 10尹伶,濮德敏.Livin与肿瘤细胞凋亡的研究现状[J].中华肿瘤防治杂志,2007,14(24):1911-1913. 被引量:3

二级参考文献26

  • 1孙建国,廖荣霞,陈正堂,王志新,张青,伍伟玲.一种新的凋亡抑制蛋白Livin在非小细胞肺癌组织中的表达[J].重庆医学,2004,33(7):982-984. 被引量:47
  • 2刘涓,陕声国,张端莲,余瑛,杨勇.毛细血管瘤组织中p63和p73基因蛋白表达的免疫组化研究[J].中华皮肤科杂志,2005,38(2):89-91. 被引量:3
  • 3吕建,陈智超.Livin与肿瘤研究新进展[J].中华肿瘤防治杂志,2006,13(17):1347-1350. 被引量:13
  • 4Benard J, Douc-Rasy S, Ahomadegbe JC. TP53 family members and human cancers. Hum Mutat, 2003, 21: 182-191.
  • 5Faridoni-Laurens L, Bosq J, Janot F, et al. p73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene,2001, 20: 5302-5312.
  • 6Puig P, Capodieci P, Drobnjak M, et al. p73 Expression in human normal and tumor tissues: loss of p73 alpha expression is associated with tumor progression in bladder cancer. Clin Cancer Res, 2003,9:5642-5651.
  • 7Kamiya M, Takeuchi Y, Katho M, et al. Expression of p73 in normal skin and proliferative skin lesions. Pathol Int, 2004, 54: 890-895.
  • 8Yokomizo A, Mai M, Tindall DJ, et al. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene, 1999, 18:1629-1633.
  • 9Tannapfel A, Wasner M, Krause K, et al. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst, 1999, 91: 1154-1158.
  • 10Tannapfel A, Engeland K, Weinans L, et al. Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer, 1999,80: 1069-1074.

共引文献3

同被引文献18

  • 1李冬,黄芳,龚树生,张鄂.凋亡抑制蛋白Survivin及Bcl-2在中耳胆脂瘤上皮中的表达及意义[J].中国耳鼻咽喉颅底外科杂志,2006,12(5):334-338. 被引量:9
  • 2田勇泉.耳鼻咽喉头颈外科学[M].8版.北京:人民卫生出版社,2013:121.
  • 3潘松林,龚树生,贺红斌.细胞外凋亡途径与中耳胆脂瘤细胞凋亡[J].中国耳鼻咽喉头颈外科,2007,14(12):699-701. 被引量:8
  • 4Fujimura M, Watanabe M, Shimizu H, et al. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2[J]. Acta Neurochir (Wien), 2007, 149(2): 179-183; discussion 183.
  • 5Ergün S, Carls?? B, Zheng X. Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear[J]. Clin Otolaryngol Allied Sci, 1999, 24(4): 280-285.
  • 6Albino AP, Reed JA, Bogdany JK, et al. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications[J]. Am J Otol, 1998, 19(1): 30-36.
  • 7Kojima H, Miyazaki H, Tanaka Y, et al. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium[J]. Arch Otolaryngol Head Neck Surg, 1999, 125(7): 738-742.
  • 8Olszewska E, Chodynicki S, Chyczewski L. Apoptosis in the pathogenesis of cholesteatoma in adults[J]. Eur Arch Otorhinolaryngol, 2006, 263(5): 409-413.
  • 9Lin SH, Deng G, Huang Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family[J]. Biochem Biophys Res Commun, 2000, 279(3): 820-831.
  • 10Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas[J]. Curr Biol, 2000, 10(21): 1359-1366.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部